INTEC PHARMA LTD. Cash and Cash Equivalents
INTEC PHARMA LTD. had Cash and Cash Equivalents of $10.13 million as of 2021-03-31, per its 10-Q filed 2021-05-17.
Discontinued › Balance Sheet › Assets › Assets, Current › Cash, Cash Equivalents, and Short-Term Investments
us-gaap:CashAndCashEquivalentsAtCarryingValue · last filed 2021-05-17
- 2021-03-31: Cash and Cash Equivalents, at Carrying Value $10.13M.
- 2020-12-31: Cash and Cash Equivalents, at Carrying Value $14.67M.
- 2020-09-30: Cash and Cash Equivalents, at Carrying Value $17.08M.
- 2020-06-30: Cash and Cash Equivalents, at Carrying Value $13.80M.
| Period end | Cash and Cash Equivalents, at Carrying Value |
|---|---|
| 2021-03-31 | $10.13M 10-Q · filed 2021-05-17 |
| 2020-12-31 | $14.67M 10-Q · filed 2021-05-17 |
| 2020-09-30 | $17.08M 10-Q · filed 2020-11-05 |
| 2020-06-30 | $13.80M 10-Q · filed 2020-08-05 |
| 2020-03-31 | $10.89M 10-Q · filed 2021-05-17 |
| 2019-12-31 | $9.29M 10-K · filed 2021-03-16 |
| 2019-09-30 | $14.97M 10-Q · filed 2020-11-05 |
| 2019-06-30 | $20.80M 10-Q · filed 2020-08-05 |
| 2019-03-31 | $31.50M 10-Q · filed 2020-05-11 |
| 2018-12-31 | $39.25M 10-K · filed 2021-03-16 |
| 2018-09-30 | $52.88M 10-Q · filed 2019-11-12 |
| 2018-06-30 | $64.63M 10-Q · filed 2019-08-09 |
| 2018-03-31 | $41.20M 10-Q · filed 2019-05-07 |
| 2017-12-31 | $53.39M 10-K · filed 2020-03-13 |
| 2016-12-31 | $16.44M 10-K · filed 2019-02-27 |